## Abstract This study assessed the futility of proceeding with a Phase 3 clinical trial of minocycline as a diseaseβmodifying treatment for Huntington's disease (HD). One hundred fourteen research participants with HD were randomized, 87 to minocycline (200 mg/d) and 27 to placebo. The change in T
Membrane studies in Huntington's disease: Steady-state fluorescence studies of intact erythrocytes
β Scribed by Jay W. Pettegrew; John S. Nichols; R. Malcolm Stewart
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 521 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The erythrocyte osmotic fragility was evaluated on 19 unmedicated subjects with Huntington's disease and 42 individuals at 50% risk, 27 children at 25% risk, and a group of 60 hematologically normal control persons. Five older subjects at 50% risk for Huntington's disease as well as 6 A
The purpose of this work was to obtain information about protein tertiary structure in solid state by using steady state tryptophan (Trp) fluorescence emission spectroscopy on protein powders. Beta-lactoglobulin (betaLg) and interferon alpha-2a (IFN) powder samples were studied by fluorescence spect
## Abstract The objective of this study is to evaluate the tolerability and preliminary efficacy of levetiracetam (LEV) in reducing chorea in Huntington's disease (HD) patients in a prospective openβlabel pilot study. Nine HD patients with chorea were treated with LEV in doses up to 3,000 mg/day fo